MarketFriction

Omkar Pharmachem Ltd

BSE 532167 · Commodity Chemicals
₹9.73 +0.00%
BSE close2026-10-01
Market cap₹9.70 Cr.
P/E108

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales0.140.140.140.140.140.140.140.140.140.110.090.09
Expenses0.050.070.060.090.050.050.070.100.070.070.070.10
Operating Profit0.090.070.080.050.090.090.070.040.070.040.02-0.01
OPM %64.29%50.00%57.14%35.71%64.29%64.29%50.00%28.57%50.00%36.36%22.22%-11.11%
Other Income0.000.000.000.000.000.000.000.000.000.000.000.00
Interest0.000.000.030.000.000.000.020.000.000.000.000.00
Depreciation0.000.000.000.000.000.000.000.000.000.000.000.00
Profit before tax0.090.070.050.050.090.090.050.040.070.040.02-0.01
Tax %0.00%0.00%120.00%0.00%0.00%0.00%140.00%25.00%28.57%25.00%0.00%0.00%
Net Profit0.090.07-0.020.050.090.08-0.020.030.050.030.02-0.01
EPS in Rs0.090.07-0.020.050.090.08-0.020.030.050.030.02-0.01
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales0.000.000.000.000.050.270.540.540.540.540.470.43
Expenses0.120.220.240.380.260.240.270.220.250.240.310.31
Operating Profit-0.12-0.22-0.24-0.38-0.210.030.270.320.290.300.160.12
OPM %-420.00%11.11%50.00%59.26%53.70%55.56%34.04%27.91%
Other Income0.000.490.000.000.000.000.000.000.000.000.010.00
Interest0.000.000.010.040.050.060.060.050.030.020.000.00
Depreciation0.000.000.000.000.000.000.000.000.000.010.000.00
Profit before tax-0.120.27-0.25-0.42-0.26-0.030.210.270.260.270.170.12
Tax %0.00%18.52%0.00%0.00%0.00%-866.67%14.29%25.93%23.08%25.93%23.53%
Net Profit-0.120.22-0.26-0.42-0.260.220.180.200.190.200.120.09
EPS in Rs-0.120.22-0.26-0.42-0.260.220.180.200.190.200.120.09
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%12%-5%-23%
Compounded Profit Growth12%-11%-16%-50%
Stock Price CAGR%-13%-23%-62%
Return on Equity0%2%1%1%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital10.0810.0810.0810.0810.0810.0810.0810.0810.0810.0810.0810.08
Reserves-0.81-0.93-0.71-0.96-1.38-1.64-1.42-1.24-1.04-0.85-0.6526.56
Borrowings0.010.000.000.240.580.870.900.930.620.300.120.00
Other Liabilities0.130.570.060.040.050.060.080.060.070.070.050.05
Total Liabilities9.419.729.439.409.339.379.649.839.739.609.6036.69
Fixed Assets0.010.010.000.010.000.000.000.010.000.010.010.00
CWIP0.000.000.000.000.000.000.000.000.000.000.000.00
Investments9.309.309.309.309.309.309.309.309.309.309.3036.38
Other Assets0.100.410.130.090.030.070.340.520.430.290.290.31
Total Assets9.419.729.439.409.339.379.649.839.739.609.6036.69
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity-0.050.34-0.77-0.25-0.30-0.210.020.200.280.300.240.23
Cash from Investing Activity0.000.000.49-0.010.000.000.00-0.010.00-0.010.000.00
Cash from Financing Activity0.00-0.010.010.230.300.24-0.02-0.03-0.35-0.35-0.20-0.12
Net Cash Flow-0.050.33-0.28-0.030.000.020.000.17-0.08-0.060.040.11
Free Cash Flow-0.050.34-0.29-0.26-0.30-0.210.020.190.280.290.240.23
CFO/OP83%-283%327%104%79%100%67%74%88%103%80%150%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days146.0040.5654.0787.8733.8067.5923.30
Inventory Days
Days Payable
Cash Conversion Cycle146.0040.5654.0787.8733.8067.5923.30
Working Capital Days-6,570.00-1,270.74-608.33-378.52-162.22-6.7623.30
ROCE %-0.64%-1.30%-2.27%-2.56%-4.08%-2.26%0.32%2.79%3.29%3.02%3.04%0.74%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters0.03%0.03%0.03%0.03%0.03%0.03%0.03%0.03%0.03%0.03%0.03%0.03%
Public99.97%99.97%99.97%99.97%99.97%99.97%99.97%99.97%99.97%99.97%99.97%99.97%
No. of Shareholders3,5903,6003,6013,6093,6083,6093,6113,6193,6183,6183,6173,669

Fundamentals

Market Cap₹ 9.70 Cr.
Current Price₹ 9.62
Stock P/E108
Book Value₹ 36.3
ROCE0.74 %
ROE0.52 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-23%
Compounded Profit Growth (TTM)-50%
Standalone figures.
Valuation
Market capRs 10 Cr
Enterprise valueRs 10 Cr
P/E (TTM)109.03x
Price to book0.27x
Price to sales22.82x
EV / EBITDA79.94x
EV / EBIT79.94x
EV / sales22.31x
Price to cash flow42.66x
Earnings yield0.92%
P/E, 3-year average172.84x
P/B, 3-year average2.16x
P/E, 5-year average151.78x
P/B, 5-year average2.32x
Profitability
Operating margin (excl. other income)34.04%
Operating margin (incl. other income)36.17%
EBITDA margin27.91%
Pre-tax margin27.91%
Net profit margin20.93%
Net margin, latest quarter-11.11%
ROE0.52%
ROCE0.74%
ROA0.52%
ROE, 3-year average1.58%
ROCE, 3-year average2.27%
ROA, 3-year average1.52%
ROE, 5-year average1.81%
ROCE, 5-year average2.58%
ROA, 5-year average1.69%
ROIC (approx.)0.25%
Tax rate23.53%
Other income / net worth0.03%
Growth
Sales growth (latest year)-12.96%
Profit growth (latest year)-40.00%
Sales CAGR, 3 years-4.52%
Sales CAGR, 5 years11.72%
Profit CAGR, 3 years-15.66%
Profit CAGR, 5 years-11.42%
Sales growth QoQ0.00%
Profit growth QoQ-150.00%
Sales growth YoY (latest quarter)-35.71%
Profit growth YoY (latest quarter)-133.33%
Per share
EPS (TTM)Rs 0.09
EPS (latest year)Rs 0.12
EPS (latest quarter)Rs -0.01
EPS, 3-year averageRs 0.17
EPS, 5-year averageRs 0.18
Book value per shareRs 36.33
Sales per shareRs 0.43
Cash flow per shareRs 0.23
Free cash flow per shareRs 0.23
Efficiency
Asset turnover0.01x
Debtor days23 days
Debtors turnover15.67x
Cash conversion cycle23 days
Working capital days23 days
Leverage
Cash and bankRs 0 Cr
Net debtRs -0 Cr
Net debt / EBITDA-1.83x
Owners' fund to total sources99.86%
Cash flow
Cash from Operating Activity (latest year)Rs 0 Cr
Cash from Financing Activity (latest year)Rs -0 Cr
Net Cash Flow (latest year)Rs 0 Cr
Free cash flow (latest year)Rs 0 Cr
Cash from ops / profit, 5 years1.40x
Sales to cash flow2.04x
Statement figures
Net sales (TTM)Rs 0 Cr
Net sales (latest year)Rs 0 Cr
Sales (latest quarter)Rs 0 Cr
Operating profit excl. other income (latest year)Rs 0 Cr
Operating profit (latest quarter)Rs -0 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 0 Cr
PBDT (TTM)Rs 0 Cr
Profit before tax (TTM)Rs 0 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs 0 Cr
Net profit (latest year)Rs 0 Cr
Net profit (latest quarter)Rs -0 Cr
Cost of goods sold (latest year)Rs 0 Cr
Total expenditure (latest year)Rs 0 Cr
Total income (latest year)Rs 0 Cr
Share capitalRs 10 Cr
ReservesRs 27 Cr
Shareholders' fundsRs 37 Cr
Total assetsRs 37 Cr
InvestmentsRs 36 Cr
ReceivablesRs 0 Cr
Other liabilitiesRs 0 Cr
Shares outstanding (crore)1.01
Ownership
Promoter holding0.03% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 109.0 is at the 30th percentile of its own 4.2-year range (median 121.9, low 42.2, high 330.6).
P/B 0.27 is the lowest in 5.3 years (median 2.45).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
Period532167Nifty 50Difference
1 week+6.6%-2.8% +9.4 pts
1 month-16.1%-6.8% -9.3 pts
3 months-46.7%-7.6% -39.0 pts
3 years-53.2%+14.2% -67.4 pts
5 years-51.0%+27.9% -78.9 pts

Red flags

F-score 5 of 8
No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹0 Cr -35.7% vs Jun 2025. Net loss ₹0 Cr.

Activity

Compare
CompanyMcap (Cr)P/EROCE
SRF Ltd71,73832.014.6 %
Deepak Fertilisers & Petrochemicals Corp Ltd16,52316.811.4 %
Tata Chemicals Ltd15,6383.42 %
Gujarat Narmada Valley Fertilizers & Chemicals Ltd8,9858.6612.0 %
Tanfac Industries Ltd7,22610723.9 %
Gujarat Alkalies & Chemicals Ltd4,60669.41.42 %
Grauer & Weil (India) Ltd3,74423.420.6 %
GHCL Ltd3,7248.1617.4 %
J.G.Chemicals Ltd2,57634.318.1 %
Thirumalai Chemicals Ltd1,834-3.15 %
I G Petrochemicals Ltd1,80122.13.11 %
Indo Borax & Chemicals Ltd1,56932.015.4 %
Innovassynth Technologies (India) Ltd1,405-16.4 %
Citurgia Biochemicals Ltd1,380%
Vikram Thermo (India) Ltd1,32030.136.2 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Omkar Pharmachem Ltd?

Omkar Pharmachem Ltd (532167) has a market capitalisation of Rs 9.70 Cr. at the 2026-10-01 close.

What is the P/E ratio of Omkar Pharmachem Ltd?

Omkar Pharmachem Ltd trades at a P/E of 108 on trailing twelve-month profit, at the 2026-10-01 close.

What were Omkar Pharmachem Ltd's latest quarterly results?

In the Jun 2026 quarter, Omkar Pharmachem Ltd sales was Rs 0 Cr (-35.7% vs Jun 2025) with a net loss of Rs 0 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03